Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/09/2010US20100310583 Let-7 microrna and mimetics thereof as therapeutics for cancer
12/09/2010US20100310582 Methods for inducing in vivo tolerance
12/09/2010US20100310581 Combination therapy of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc)
12/09/2010US20100310580 Compositions and methods for treating pruritus
12/09/2010US20100310579 Method for inhibiting angiogenesis or for treatment of cancer
12/09/2010US20100310578 Use of lipocalin-2 as a diagnostic marker and therapeutic target
12/09/2010US20100310577 Methods for increasing thermogenic adipocytes
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310575 Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders
12/09/2010US20100310574 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
12/09/2010US20100310573 Anti-cd4 antibody
12/09/2010US20100310572 Binding molecules capable of neutralizing rabies virus and uses thereof
12/09/2010US20100310571 Uses of monoclonal antibody 8h9
12/09/2010US20100310570 Mapc treatment of brain injuries and diseases
12/09/2010US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
12/09/2010US20100310568 Ninjurin-1 modulation and uses thereof
12/09/2010US20100310567 Antibodies Against Human CCN1 and Uses Thereof
12/09/2010US20100310566 Fibroblast Growth Factor-Like Polypeptides
12/09/2010US20100310565 Antibodies that bind both il-17a and il-17f and methods of using the same
12/09/2010US20100310564 Method for the Treatment of Glomerulonephritis
12/09/2010US20100310563 Methods for treating induced cellular proliferative disorders
12/09/2010US20100310562 System for delivery into xcr1 positive cell and uses thereof
12/09/2010US20100310561 Natriuretic fusion proteins
12/09/2010US20100310560 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/09/2010US20100310559 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits
12/09/2010US20100310558 Method for Linking Sequences of Interest
12/09/2010US20100310557 Antibodies immunoreactive with heregulin-coupled her3
12/09/2010US20100310556 Therapeutic agent for pruritus
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310554 Methods for Reversing Multiple Resistance in Animal Cells
12/09/2010US20100310553 Compositions and Methods for Controlling Hepatitis C Virus Infection
12/09/2010US20100310552 Antibodies produced in the avian oviduct
12/09/2010US20100310551 Immunogenic, monoclonal antibody
12/09/2010US20100310550 Alpha 1- antitrypsin compositions
12/09/2010US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors
12/09/2010US20100310548 Methods of Manufacturing a Biologic Using a Stable Storage Intermediate
12/09/2010US20100310547 Treatment of Inflammatory Diseases
12/09/2010US20100310516 Duplexed Parvovirus Vectors
12/09/2010US20100310507 Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/09/2010US20100310506 Immunoconjugates for the Treatment of Tumours
12/09/2010US20100310504 Methods for treating fibrosis by modulating cellular senescence
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010US20100310472 Dna sequence, and recombinant preparation of the grass pollen allergen lol p 4
12/09/2010US20100310469 Vaccine immunotherapy for immune suppressed patients
12/09/2010US20100310464 Antibodies
12/09/2010US20100310463 Anti-EpCAM Antibodies
12/09/2010US20100310454 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and /or their cancerous counterpart
12/09/2010US20100310453 Heterologous antibodies which bind human cd4
12/09/2010CA2764424A1 Vaccine for mycoplasma infection
12/09/2010CA2764406A1 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
12/09/2010CA2764022A1 Combinations of pneumococcal rrgb clades
12/09/2010CA2763492A1 Biomaterials, compositions, and methods
12/09/2010CA2763075A1 Recombinantly produced allergens
12/09/2010CA2762375A1 Antibodies against human ccn1 and uses thereof
12/09/2010CA2762206A1 Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9
12/09/2010CA2761733A1 Reagents and methods for detecting influenza virus proteins
12/09/2010CA2761262A1 Recombinant subunit west nile virus vaccine for protection of human subjects
12/08/2010EP2258869A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258868A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258867A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258851A1 Combination neisserial compositions
12/08/2010EP2258850A1 Recombinant viral-based malaria vaccines
12/08/2010EP2258849A1 Mammalian receptor proteins; related reagents and methods
12/08/2010EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof
12/08/2010EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258727A1 Immunoglobulin preparation for the treatment of autoimmune diseases and immune system disorders
12/08/2010EP2258726A1 High affinity human antibodies to c-erbB-2
12/08/2010EP2258724A1 Modulating immune responses using multimerized anti-CD83 antibodies
12/08/2010EP2258723A1 Treatment of oncostatin M receptor ß mediated heart failure
12/08/2010EP2258718A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258717A2 Variant form of meningococcal NadA
12/08/2010EP2258716A2 Multiple variants of meningococcal protein NMB1870
12/08/2010EP2258714A1 Improved analytical method for the detection of latent hepatitis c, use thereof and corresponding diagnosis kit
12/08/2010EP2258712A2 Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs
12/08/2010EP2258392A1 Method of administering therapeutic polypeptides
12/08/2010EP2258391A1 Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoids
12/08/2010EP2258390A1 Improved bacterial outer membrane vesicles
12/08/2010EP2258389A1 Improved bacterial outer membrane vesicles
12/08/2010EP2258388A1 Improved bacterial outer membrane vesicles
12/08/2010EP2258387A2 Neisseria vaccine composition
12/08/2010EP2258386A2 Neisseria Vaccine composition
12/08/2010EP2258385A2 Neisseria vaccine composition
12/08/2010EP2258384A2 Neisseria vaccine composition
12/08/2010EP2258383A2 Antigenic peptides derived from telomerase
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2258361A1 Use of benzophenone derivative or salt thereof and tnf inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
12/08/2010EP2257806A1 Compositions and methods for identifying response targets and treating flavivirus infection responses
12/08/2010EP2257308A2 Recombinant rhinovirus vectors
12/08/2010EP2257307A2 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
12/08/2010EP2257306A1 Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
12/08/2010EP2257301A2 Allogeneic cancer cell-based immunotherapy
12/08/2010EP2257299A1 Modulation of srpx2-mediated angiogenesis
12/08/2010EP2257293A2 Combination therapy with c-met and egfr antagonists
12/08/2010EP1994943B1 Chimeric vaccine antigens against classical swine fever virus
12/08/2010EP1652925B1 IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION
12/08/2010EP1598369B1 Anti tgr23-2 ligand antibodies and uses thereof
12/08/2010EP1551867B1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1494693B1 Cripto-specific antibodies
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 1823